Skip to main content
Clinical Trials/CTRI/2020/04/024818
CTRI/2020/04/024818
Recruiting
未知

A Randomized study to compare vaginal and sublingual routes of misoprostol following mifepristone for second trimester medical termination of pregnancy

PGIMER0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O048- (Induced) termination of pregnancywith other and unspecified complications
Sponsor
PGIMER
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
PGIMER

Eligibility Criteria

Inclusion Criteria

  • 1\.Females in above mentioned age group with singleton viable intrauterine pregnancy
  • 2\.Gestational age 13\-20weeks
  • 3\.Women fulfilling the pre\-requisites of Indian MTP Act, 1972

Exclusion Criteria

  • 1\.Prior 2 or more uterine surgeries
  • 2\.Having either taken MTP pill from outside or self prescribed or with inevitable or incomplete abortion
  • 3\.Moderate or severe anaemia(Hb \<8gm/dl)
  • 4\.Heart disease, uncontrolled HTN(140/90mmHg), bronchial asthma, coagulation disorder and any other medical illness
  • 5\.Known hypersenstivity to mifepristone or misoprostol
  • 6\.Hemodynamically unstable at the time of presentation
  • 7\.Contra\-indications to the use of mifepristone or misoprostol like ectopic pregnancy, inherited porphyria, chronic adrenal failure , on immunosuppressants
  • 8\.Presence of vaginal discharge suggestive of vaginitis

Outcomes

Primary Outcomes

Not specified

Similar Trials